Revealix Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Angel
  • Investors
  • 8

Revealix General Information

Description

Developer of a digital health platform intended to drive early identification and engagement of at-risk diabetic patients. The company leverages technology to provide diabetic limb surveillance and preemptive monitoring through mobile imaging and connected health tools, enabling clients to properly detect and prevent diabetic limb complications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Clinics/Outpatient Services
Decision/Risk Analysis
Primary Office
  • 3801 North Capital Of Texas Highway
  • Suite E240
  • Austin, TX 78746
  • United States
+1 (408) 000-0000

Revealix Timeline

2019202020212022
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Revealix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Angel (individual) 20-Jan-2021 0000 Completed Startup
6. Accelerator/Incubator 12-Sep-2019 0000 0000 00000 Completed Startup
5. Accelerator/Incubator 01-Jan-2018 Completed Startup
4. Accelerator/Incubator Completed Startup
3. Accelerator/Incubator 09-Dec-2016 Completed Startup
2. Accelerator/Incubator 01-Jan-2016 Completed Startup
1. Accelerator/Incubator 01-Jan-2015 Completed Startup
To view Revealix’s complete valuation and funding history, request access »

Revealix Patents

Revealix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160100790-A1 Automated systems and methods for skin assessment and early detection of a latent pathogenic bio-signal anomaly Granted 08-Oct-2014 000000000 00
US-10117617-B2 Automated systems and methods for skin assessment and early detection of a latent pathogenic bio-signal anomaly Active 08-Oct-2014 000000000 00

Revealix Executive Team (2)

Name Title Board Seat Contact Info
Adrianna Cantu Co-Founder & Chief Executive Officer
Gary Johnson Co-Founder
To view Revealix’s complete executive team members history, request access »

Revealix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Revealix Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Beam Angel Network Angel Group Minority 000 0000 000000 0
Techstars Accelerator/Incubator Minority 000 0000 000000 0
TMC Innovation Accelerator/Incubator 000 0000 000000 0
DivInc Accelerator/Incubator Minority 000 0000 000000 0
Tarmac TX Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »